New Indole Derivatives As Multitarget anti-Alzheimer's Agents: synthesis, Biological Evaluation and Molecular Dynamics

References

• Walsh DM , SelkoeDJ. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron44(1), 181–193 (2004).
   PubMed Web of Science ®Google Scholar
• Pappolla MA , PerryG, FangX, ZagorskiM, SambamurtiK, PoeggelerB. Indoles as essential mediators in the gut–brain axis. Their role in Alzheimer's disease. Neurobiol. Dis.156, 105403 (2021).
   PubMed Web of Science ®Google Scholar
• Kareem RT , AbedinifarF, MahmoodEA, EbadiAG, RajabiF, VessallyE. The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020. RSC Adv.11(49), 30781–30797 (2021).
   PubMed Web of Science ®Google Scholar
• Selkoe DJ . Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev.81(2), 741–766 (2001).
   PubMed Web of Science ®Google Scholar
• Bartolini M , BertucciC, CavriniV, AndrisanoV. β-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem. Pharmacol.65(3), 407–416 (2003).
   PubMed Web of Science ®Google Scholar
• Muñoz-Ruiz P , RubioL, García-PalomeroEet al. Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease. J. Med. Chem.48(23), 7223–7233 (2005).
   PubMed Web of Science ®Google Scholar
• Sreenivasachary N , KrothH, BenderitterPet al. Discovery and characterization of novel indole and 7-azaindole derivatives as inhibitors of β-amyloid-42 aggregation for the treatment of Alzheimer's disease. Bioorg. Med. Chem. Lett.27(6), 1405–1411 (2017).
   PubMed Web of Science ®Google Scholar
• Wang JZ , LiuF. Microtubule-associated protein tau in development, degeneration, and protection of neurons. Prog. Neurobiol.85(2), 148–175 (2008).
   PubMed Web of Science ®Google Scholar
• Gu F , ZhuM, ShiJ, HuY, ZhaoZ. Enhanced oxidative stress is an early event during development of Alzheimer-like pathologies in presenilin conditional knock-out mice. Neurosci. Lett.440(1), 44–48 (2008).
   PubMed Web of Science ®Google Scholar
• Bezprozvanny I . Amyloid goes global. Sci. Signal.2(63), 16 (2009).
   Web of Science ®Google Scholar
• Von Bernhardi R , EugenínJ. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. ARS16(9), 974–1031 (2012).
   Google Scholar
• Grimm A , FriedlandK, EckertA. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease. Biogerontology17(2), 281–296 (2016).
   PubMed Web of Science ®Google Scholar
• Polanco JC , LiC, BodeaLG, Martinez-MarmolR, MeunierFA, GötzJ. Amyloid-β and tau complexity – towards improved biomarkers and targeted therapies. Nat. Rev. Neuro.14(1), 22–39 (2018).
   PubMed Web of Science ®Google Scholar
• Zhou LC , LiangYF, HuangYet al. Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dual-functional agents for the treatment of Alzheimer's disease. Eur. J. Med. Chem.219, 113426 (2021).
   PubMed Web of Science ®Google Scholar
• Vrabec R , MaříkováJ, LočárekMet al. Monoterpene indole alkaloids from Vinca minor L. (Apocynaceae): identification of new structural scaffold for treatment of Alzheimer's disease. Phytochemistry194, 113017 (2022).
   PubMed Web of Science ®Google Scholar
• Morphy R , RankovicZ. Designed multiple ligands. An emerging drug discovery paradigm. J. Med. Chem.48(21), 6523–6543 (2005).
   PubMed Web of Science ®Google Scholar
• Cavalli A , BolognesiML, MinariniAet al. Multi-target-directed ligands to combat neurodegenerative diseases. J. Med. Chem.51(3), 347–372 (2008).
   PubMed Web of Science ®Google Scholar
• Benek O , KorabecnyJ, SoukupO. A perspective on multi-target drugs for Alzheimer's disease. Trends Pharmaco. Sci.41(7), 434–445 (2020).
   PubMed Web of Science ®Google Scholar
• Yıldız M , BingulM, ZorluYet al. Dimethoxyindoles based thiosemicarbazones as multi-target agents; synthesis, crystal interactions, biological activity and molecular modeling. Bioorg. Chem.120, 105647 (2022).
   PubMed Web of Science ®Google Scholar
• Makarian M , GonzalezM, SalvadorSM, LorzadehS, HudsonPK, PecicS. Synthesis, kinetic evaluation and molecular docking studies of donepezil-based acetylcholinesterase inhibitors. J. Mol. Struct.1247, 131425 (2022).
   PubMed Web of Science ®Google Scholar
• Sahin Z , BiltekinSN, YurttaşL, BerkB, KüçükkılınçTT, DemirayakŞ. Novel benzofurane carbonyl analogs of donepezil as acetylcholinesterase inhibitors. J. Mol. Struct.1264, 133193 (2022).
   Web of Science ®Google Scholar
• Ren B , GuoC, LiuRet al. Imidazolylacetophenone oxime-based multifunctional neuroprotective agents: discovery and structure–activity relationships. Eur. J. Med. Chem.228, 114031 (2022).
   PubMed Web of Science ®Google Scholar
• Mahmoud Z , SayedHS, MohamedLW, MohamedKO. Development of new donepezil analogs: synthesis, biological screening and in silico study rational. Med. Chem. Res.31(10), 1754–1770 (2022).
   Web of Science ®Google Scholar
• Taha M , RahimF, UddinNet al. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors. Int. J. Biol. Macromol.188, 1025–1036 (2021).
   PubMed Web of Science ®Google Scholar
• Purgatorio R , de CandiaM, CattoMet al. Investigating 1, 2, 3, 4, 5, 6-hexahydroazepino [4,3-b] indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease. Eur. J. Med. Chem.177, 414–424 (2019).
   PubMed Web of Science ®Google Scholar
• Lamie PF , Abdel-FattahMM, PhiloppesJN. Design and synthesis of new indole drug candidates to treat Alzheimer's disease and targeting neuro-inflammation using a multi-target-directed ligand (MTDL) strategy. J. Enzyme Inhib. Med. Chem.37(1), 2660–2678 (2022).
   PubMed Web of Science ®Google Scholar
• Khan S , IqbalS, TahaMet al. Synthesis, in vitro biological evaluation and in silico molecular docking studies of indole based thiadiazole derivatives as dual inhibitor of acetylcholinesterase and butyrylchloinesterase. Molecules27(21), 7368 (2022).
   PubMed Web of Science ®Google Scholar
• Ferreira JPS , AlbuquerqueHMT, CardosoSM, SilvaAMS, SilvaVLM. Dual-target compounds for Alzheimer's disease: natural and synthetic AChE and BACE-1 dual inhibitors and their structure–activity relationship (SAR). Eur. J. Med. Chem.221, 113492–113518 (2021).
   PubMed Web of Science ®Google Scholar
• Zhipei S , KerenW, PingBet al. Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease. Eur. J. Med. Chem.194, 112265–112289 (2020).
   PubMed Web of Science ®Google Scholar
• Wang H , ZhangH. Reconsideration of anticholinesterase therapeutic strategies against Alzheimer's disease. ACS Chem. Neurosci.10(2), 852–862 (2019).
   PubMed Web of Science ®Google Scholar
• Yuying F , WenjuanX, BaoCet al. Design, synthesis, and biological evaluation of compounds with a new scaffold as anti-neuroinflammatory agents for the treatment of Alzheimer's disease. Eur. J. Med. Chem.149, 129–138 (2018).
   PubMed Web of Science ®Google Scholar
• Choubey PK , TripathiA, SharmaP, ShrivastavaSK. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease. Bioorg. Med. Chem.28(22), 115721 (2020).
   PubMed Web of Science ®Google Scholar
• Wang XB , YinFC, HuangM, JiangN, LanJS, KongLY. Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease. RSC Med. Chem.11(2), 225–233 (2020).
   PubMedGoogle Scholar
• Saeedi M , Mohtadi-HaghighiD, MirfazliSSet al. Design and synthesis of selective acetylcholinesterase inhibitors: arylisoxazole-phenylpiperazine derivatives. Chem. Biodiv.16(2), e1800433 (2019).
   PubMed Web of Science ®Google Scholar
• van Greunen DG , CordierW, NellMet al. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil. Eur. J. Med. Chem.127, 671–690 (2017).
   PubMed Web of Science ®Google Scholar
• Costanzo P , CariatiL, DesiderioDet al. Design, synthesis, and evaluation of donepezil-like compounds as AChE and BACE-1 inhibitors. ACS Med. Chem. Lett.7(5), 470–475 (2016).
   PubMed Web of Science ®Google Scholar
• Gulcan HO , UnluS, EsiringuIet al. Design, synthesis and biological evaluation of novel 6H-benzo [c] chromen-6-one, and 7, 8, 9, 10-tetrahydro-benzo [c] chromen-6-one derivatives as potential cholinesterase inhibitors. Bioorg. Med. Chem.22(19), 5141–5154 (2014).
   PubMed Web of Science ®Google Scholar
• Ismail MM , KamelMM, MohamedLW, FaggalSI, GalalMA. Synthesis and biological evaluation of thiophene derivatives as acetylcholinesterase inhibitors. Molecules17(6), 7217–7231 (2012).
   PubMed Web of Science ®Google Scholar
• Ahmad M . Donepezil: a review of the recent structural modifications and their impact on anti-Alzheimer activity. Braz. J. Pharm. Sci.56, e18325 (2020).
   Web of Science ®Google Scholar
• Wang J , WangZM, LiXMet al. Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin. Bioorg. Med. Chem.24(18), 4324–4338 (2016).
   PubMed Web of Science ®Google Scholar
• Pudlo M , LuzetV, IsmaïliL, TomassoliI, IutzelerA, RefouveletB. Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease. Bioorg. Med. Chem.22(8), 2496–2507 (2014).
   PubMed Web of Science ®Google Scholar
• Liu D , ZhangF, GaoM, ZhouJ, WangY, LuY. Pt nanoparticle/N-doped graphene nanozymes for colorimetric detection of acetylcholinesterase activity and inhibition. Chin. J. Anal. Chem.50(12), 100177 (2022).
   Web of Science ®Google Scholar
• Taha M , AlshamraniFJ, RahimFet al. Synthesis, characterization, biological evaluation, and kinetic study of indole base sulfonamide derivatives as acetylcholinesterase inhibitors in search of potent anti-Alzheimer agent. J. King Saud. Univ. Sci.33(3), 101401 (2021).
   Web of Science ®Google Scholar
• Barril X , KalkoSG, OrozcoM, LuqueF. Rational design of reversible acetylcholinesterase inhibitors. Mini-Rev. Med. Chem.2, 27–36 (2002).
   PubMed Web of Science ®Google Scholar
• Yi C , XueY, ChenKet al. Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl) phenyl) sulfonyl)-1H-indole scaffold as potent 5-HT6R antagonists: design, synthesis, biological evaluation, and early in vivo cognition-enhancing studies. Bioorg. Med. Chem.70, 116917 (2022).
   PubMed Web of Science ®Google Scholar
• Gopi C , DhanarajuMD. Synthesis and antioxidant properties of 2-(3-(hydroxyimino) methyl)-1 H-indol-1-yl) acetamide derivatives.. FJPS6, 1–10 (2020).
   Google Scholar
• Zada H , UllahH, HayatS, RahimF, KhanF, WadoodA. Synthesis of triazinoindole bearing sulfonamide derivatives, in vitro – amylase activity and their molecular docking study. Chem. Data Collect.39, 100875 (2002).
   Google Scholar
• Ozgun DO , YamaliC, GulHIet al. Inhibitory effects of isatin Mannich bases on carbonic anhydrases, acetylcholinesterase, and butyrylcholinesterase. J. Enzyme Inhib. Med. Chem.31(6), 1498–1501 (2016).
   PubMed Web of Science ®Google Scholar
• Recanatini M , CavalliA, BellutiFet al. SAR of 9-amino-1,2,3,4-tetrahydroacrydine-based acetylcholinesterase inhibitors synthesis, enzyme inhibitory activity, QSAR and structure-based COMFA of tacrine analogues. J. Med. Chem.43, 2007–2018 (2000).
   PubMed Web of Science ®Google Scholar
• Zhao Y , DuSK, WangH, CaiM. In vitro antioxidant activity of extracts from common legumes. Food Chem.152, 462–466 (2014).
   PubMed Web of Science ®Google Scholar
• Baliyan S , MukherjeeR, PriyadarshiniAet al. Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of Ficus religiosa. Molecules27(4), 1326 (2022).
   PubMed Web of Science ®Google Scholar
• Cheung J , RudolphMJ, BurshteynFet al. Height structures of human acetylcholinesterase in complex with pharmacologically important ligands. J. Med. Chem.55(22), 10282–10286 (2012).
   PubMed Web of Science ®Google Scholar
• Meden A , KnezD, JukičMet al. Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease. Chem. Comm.55(26), 3765–3768 (2019).
   PubMed Web of Science ®Google Scholar
• Lountos GT , JiangR, WellbornWB, ThalerTL, BommariusAS, OrvilleAM. The crystal structure of NAD (P) H oxidase from Lactobacillus sanfranciscensis: insights into the conversion of O2 into two water molecules by the flavoenzyme. Biochem45(32), 9648–9659 (2006).
   PubMed Web of Science ®Google Scholar
• Hu Y , WuY, JiangCet al. Investigative on the molecular mechanism of licorice flavonoids anti-melanoma by network pharmacology, 3D/2D-QSAR, molecular docking, molecular dynamics simulation. Front. Chem.10, 843970 (2022).
   PubMed Web of Science ®Google Scholar
• Han Y , ZhangJ, HuCQ, ZhangX, MaB, ZhangP. In silico ADME and toxicity prediction of ceftazidime and its impurities. Front. Pharmacol.10, 434 (2019).
   PubMed Web of Science ®Google Scholar
• Flefel EE , SalamaMA, El-ShahatM, El-HashashMA, El-FarargyAF. A novel synthesis of some new pyrimidine and thiazolopyrimidine derivatives for anticancer evaluation. Phosphorus Sulfur Silicon Relat. Elem.182(8), 1739–1756 (2007).
   Web of Science ®Google Scholar
• Gök M , MadrerN, ZorbazTet al. Altered levels of variant cholinesterase transcripts contribute to the imbalanced cholinergic signaling in Alzheimer's and Parkinson's disease. Front. Mol. Neurosci.15, 941467 (2022).
   PubMed Web of Science ®Google Scholar